Royalty Pharma Future Growth

How is Royalty Pharma forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

[object Object] Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


59.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:RPRX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20242,8842,1472,4292,4687
12/31/20232,6341,1592,1792,2197
12/31/20222,8576992,6432,3636
9/30/20222,2475074012,064N/A
6/30/20222,2594663121,995N/A
3/31/20222,2786022631,952N/A
12/31/20212,289620-1742,018N/A
9/30/20212,286783-7322,093N/A
6/30/20212,239972-1592,132N/A
3/31/20212,195493-4962,090N/A
12/31/20202,122495-1482,035N/A
9/30/20202,0081,7451041,947N/A
6/30/20201,9341,8637931,858N/A
3/31/20201,8802,0521,0931,705N/A
12/31/20191,8142,349-541,667N/A
12/31/20181,7951,3781,3491,618N/A
12/31/20171,5981,210-8721,418N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RPRX's forecast earnings growth (59.7% per year) is above the savings rate (2%).

Earnings vs Market: RPRX's earnings (59.7% per year) are forecast to grow faster than the US market (15.1% per year).

High Growth Earnings: RPRX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: RPRX's revenue (4.7% per year) is forecast to grow slower than the US market (7% per year).

High Growth Revenue: RPRX's revenue (4.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: RPRX's Return on Equity is forecast to be high in 3 years time (26.2%)


Discover growth companies